"Retina Consultants of Texas provides world-class retina care to patients across Houston. Visit our retina center in Northern Houston to get top retina specialist care for wet & dry macular degeneration (AMD), diabetic retinopathy, retinal tears & detachments, uveitis, flashes & floaters, and more. We offer a full spectrum of retinal diagnostics (fluorescein angiography, etc.) and treatments such as eye injections (Avastin, Lucentis, Eylea), vitrectomy, and scleral buckle. Our retina research center is the largest in the country. We participate in many cutting-edge clinical trials for new & improved retina care. Our Northern Houston retina center on Peakwood is easily accessible from Klein, Westfield, Louetta, Aldine, Kohrville, and more."

During the past decade, Retina Consultants of Houston conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 37 clinical trials were completed, i.e. on average, 64.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 22 clinical trials were completed. i.e. 129.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Consultants of Houston" #1 sponsor was "Jaeb Center for Health Research" with 9 trials, followed by "ThromboGenics" with 8 trials sponsored, "Clearside Biomedical, Inc." with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Apellis Pharmaceuticals, Inc." with 5 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Consultants of Houston" #1 collaborator was "National Eye Institute (NEI)" with 12 trials as a collaborator, "Genentech, Inc." with 8 trials as a collaborator, "Regeneron Pharmaceuticals" with 7 trials as a collaborator, "Allergan" with 5 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Retina Consultants of Houston" are "Diabetic Macular Edema" (23 trials), "Diabetic Retinopathy" (9 trials), "Macular Degeneration" (9 trials), "Geographic Atrophy" (7 trials) and "Macular Edema" (7 trials). Many other conditions were trialed in "Retina Consultants of Houston" in a lesser frequency.

Most popular intervention types in "Retina Consultants of Houston" are "Drug" (84 trials), "Other" (18 trials), "Procedure" (8 trials), "Device" (7 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Sham Procedure" (11 trials), "Ranibizumab" (6 trials), "Sham injection" (6 trials) and "Aflibercept" (5 trials). Other intervention names were less common.

The vast majority of trials in "Retina Consultants of Houston" are 104 trials for "All" genders.

Currently, there are NaN active trials in "Retina Consultants of Houston". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Retina Consultants of Houston, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Consultants of Houston, 15 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".